{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:12:51Z","timestamp":1788783171674,"version":"build-2803163510"},"reference-count":37,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>No randomised controlled trials (RCTs) have compared inhaled corticosteroid (ICS)\/formoterol reliever-based stepwise algorithms with short-acting \u03b2-agonist (SABA) reliever-based stepwise algorithms, titrated to levels of asthma control and exacerbations. Knowledge gaps remain in understanding ICS exposure over time, transitions between treatment steps, efficacy and participant satisfaction with different algorithm approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the study is to determine the exposure to ICS in adults and adolescents aged 16 to 75\u2005years treated with a budesonide\/formoterol reliever-based algorithm (Algorithm 1) compared to a salbutamol reliever-based algorithm (Algorithm 2) across the spectrum of asthma severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is an investigator-initiated, 52-week, single-site, open-label, parallel-groups, 2-arm RCT of 152 adults and adolescents with mild, moderate and moderate\u2013severe asthma (ACTRN12624001488594). Participants will be randomly allocated in a 1:1 ratio to a budesonide\/formoterol reliever-based or a salbutamol reliever-based algorithm. Global Initiative for Asthma (GINA) treatment step at enrolment according to the 2024 GINA Guidelines will be used to allocate participants to the corresponding steps of each algorithm. Treatment step transition will be in response to asthma exacerbations and level of asthma control. Those experiencing exacerbations or poorly controlled asthma will be stepped up, and those well controlled stepped down. The primary outcome is ICS exposure. Important secondary outcomes include composite systemic corticosteroid exposure, rates of asthma exacerbations, asthma control, T-helper 2 biomarkers, spirometry and participants\u2019 treatment perceptions and satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first RCT to compare ICS\/formoterol- and SABA-based reliever stepwise algorithmic approaches in asthma, with treatment adjusted according to asthma control and exacerbations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00009-2026","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:05:19Z","timestamp":1783616719000},"page":"00009-2026","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A study protocol for a randomised controlled trial of two stepwise pharmacological treatment approaches to adult asthma: inhaled corticosteroid\/formoterol reliever-\n                    <i>versus<\/i>\n                    short-acting \u03b2\n                    <sub>2<\/sub>\n                    -agonist reliever-based therapy \u2013 Asthma on TRACK"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-9109","authenticated-orcid":false,"given":"Ross","family":"Sayers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5864-7915","authenticated-orcid":false,"given":"Ryan","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7620-3125","authenticated-orcid":false,"given":"Jon","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allie","family":"Eathorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Weatherall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0337-406X","authenticated-orcid":false,"given":"Richard","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2026090704550739000_12.5.00009-2026.1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004589"},{"key":"2026090704550739000_12.5.00009-2026.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081660"},{"key":"2026090704550739000_12.5.00009-2026.3","unstructured":"Global Initiative for Asthma . 1995 GINA Main Report. Date last updated: January 1995. Date last accessed: 5 April 2026. https:\/\/ginasthma.org\/archived-reports\/"},{"key":"2026090704550739000_12.5.00009-2026.4","unstructured":"Global Initiative for Asthma . 2024 GINA Main Report. Date last updated: May 2024. https:\/\/ginasthma.org\/wp-content\/uploads\/2025\/05\/GINA-2024-strategy-report_24_05_22-WMSA.pdf"},{"key":"2026090704550739000_12.5.00009-2026.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.2769"},{"key":"2026090704550739000_12.5.00009-2026.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00625-2020"},{"key":"2026090704550739000_12.5.00009-2026.7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaip.2023.01.002","article-title":"The ICS\/formoterol reliever therapy regimen in asthma: a review","volume":"11","author":"Beasley","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026090704550739000_12.5.00009-2026.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2021-111764"},{"key":"2026090704550739000_12.5.00009-2026.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.22700"},{"key":"2026090704550739000_12.5.00009-2026.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200401-033OC"},{"key":"2026090704550739000_12.5.00009-2026.11","doi-asserted-by":"crossref","first-page":"103570","DOI":"10.1016\/j.eclinm.2025.103570","article-title":"An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trial","volume":"89","author":"Bruce","year":"2025","journal-title":"eClinicalMedicine"},{"key":"2026090704550739000_12.5.00009-2026.12","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.jaip.2022.08.017","article-title":"The asthma impairment and risk questionnaire (AIRQ) control level predicts future risk of asthma exacerbations","volume":"10","author":"Beuther","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026090704550739000_12.5.00009-2026.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.10.008"},{"key":"2026090704550739000_12.5.00009-2026.14","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14a08.x"},{"key":"2026090704550739000_12.5.00009-2026.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2005.00066.x"},{"key":"2026090704550739000_12.5.00009-2026.16","doi-asserted-by":"crossref","first-page":"1351851","DOI":"10.3389\/fphar.2024.1351851","article-title":"Development and validation of the BMQ-AIR: a screening tool for assessing patients\u2019 treatment beliefs about switching to anti-inflammatory reliever therapy","volume":"15","author":"Foot","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026090704550739000_12.5.00009-2026.17","doi-asserted-by":"publisher","DOI":"10.1080\/08870449908407311"},{"key":"2026090704550739000_12.5.00009-2026.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-710ST"},{"key":"2026090704550739000_12.5.00009-2026.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2026090704550739000_12.5.00009-2026.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2026090704550739000_12.5.00009-2026.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2026090704550739000_12.5.00009-2026.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2026090704550739000_12.5.00009-2026.23","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00701-2020"},{"key":"2026090704550739000_12.5.00009-2026.24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026090704550739000_12.5.00009-2026.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-1868CI"},{"key":"2026090704550739000_12.5.00009-2026.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0871"},{"key":"2026090704550739000_12.5.00009-2026.27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202402-0368OC","article-title":"Association of dose of inhaled corticosteroids and frequency of adverse events","volume":"211","author":"Bloom","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026090704550739000_12.5.00009-2026.28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaip.2023.09.034","article-title":"Comorbidity burden in severe and nonsevere asthma: a nationwide observational study","volume":"12","author":"Kankaanranta","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026090704550739000_12.5.00009-2026.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2009.01589.x"},{"key":"2026090704550739000_12.5.00009-2026.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03029.x"},{"key":"2026090704550739000_12.5.00009-2026.31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12890-019-1025-1","article-title":"Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia","volume":"19","author":"Ekbom","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2026090704550739000_12.5.00009-2026.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01714-5"},{"key":"2026090704550739000_12.5.00009-2026.33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.587"},{"key":"2026090704550739000_12.5.00009-2026.34","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01357-2024"},{"key":"2026090704550739000_12.5.00009-2026.35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/02770903.2018.1490751","article-title":"Effectiveness of fluticasone furoate\/vilanterol versus fluticasone propionate\/salmeterol on asthma control in the Salford Lung Study","volume":"56","author":"Jacques","year":"2019","journal-title":"J Asthma"},{"key":"2026090704550739000_12.5.00009-2026.36","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(17)32397-8","article-title":"Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial","volume":"390","author":"Woodcock","year":"2017","journal-title":"Lancet"},{"key":"2026090704550739000_12.5.00009-2026.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.07.014"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00009-2026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:55:18Z","timestamp":1788782118000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00009-2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,7]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1183\/23120541.00009-2026"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00009-2026","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}